HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Casadevall Selected Research

cryptococcal polysaccharide

5/2001Serologic evidence for Cryptococcus neoformans infection in early childhood.
2/2000Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Casadevall Research Topics

Disease

17Infections
12/2007 - 01/2000
8Cryptococcosis
12/2007 - 01/2000
6Mycoses (Diseases, Fungus)
06/2012 - 01/2000
3Melanoma (Melanoma, Malignant)
01/2018 - 07/2008
3Neoplasms (Cancer)
03/2013 - 09/2006
1Head and Neck Neoplasms (Head and Neck Cancer)
03/2013
1Squamous Cell Carcinoma of Head and Neck
03/2013
1Papilloma (Papillomatosis)
03/2013
1Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2013
1Asthma (Bronchial Asthma)
04/2012
1Communicable Diseases (Infectious Diseases)
09/2006
1Pneumococcal Infections
05/2004
1Acquired Immunodeficiency Syndrome (AIDS)
10/2003
1Paracoccidioidomycosis (South American Blastomycosis)
09/2001
1Tuberculosis (Tuberculoses)
09/2001
1Vomiting
05/2001
1Meningoencephalitis
03/2001
1Opportunistic Infections (Opportunistic Infection)
12/2000
1Granuloma
02/2000
1Candidiasis (Moniliasis)
01/2000

Drug/Important Bio-Agent (IBA)

7Melanins (Melanin)IBA
01/2018 - 05/2000
7Monoclonal AntibodiesIBA
03/2013 - 01/2000
6AntibodiesIBA
01/2018 - 01/2000
5AntigensIBA
06/2012 - 01/2000
4Immunoglobulin G (IgG)IBA
01/2018 - 09/2001
4Immunoglobulin M (IgM)IBA
01/2018 - 02/2001
3CytokinesIBA
10/2001 - 01/2000
2glucuronoxylomannanIBA
09/2006 - 01/2000
2Immunoglobulins (Immunoglobulin)IBA
10/2001 - 09/2001
2Polysaccharides (Glycans)IBA
10/2001 - 07/2000
2cryptococcal polysaccharideIBA
05/2001 - 02/2000
1Indicators and Reagents (Reagents)IBA
01/2018
1Cisplatin (Platino)FDA LinkGeneric
03/2013
1Oncogene Proteins (Oncogene Protein)IBA
03/2013
1Fungal AntigensIBA
06/2012
1Fungal ProteinsIBA
04/2012
1Immunoglobulin A (IgA)IBA
04/2012
1ChitinasesIBA
04/2012
1Rhenium-188IBA
09/2006
1Bismuth-213IBA
09/2006
1Anti-Infective Agents (Microbicides)IBA
06/2006
1Fluconazole (Zonal)FDA LinkGeneric
10/2003
1Immunologic Factors (Immunomodulators)IBA
10/2001
1Interleukin-12 (IL 12)IBA
10/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2001
1Culture MediaIBA
09/2001
1Polysorbates (PSML)FDA Link
09/2001
1Glyphosate (Roundup)IBA
04/2001
1Chemotactic FactorsIBA
08/2000
1Pharmaceutical PreparationsIBA
05/2000
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2000
1UreaseIBA
02/2000
1GlucocorticoidsIBA
02/2000
1Virulence Factors (Pathogenicity Factors)IBA
02/2000
1lipoarabinomannan (LAM)IBA
01/2000
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2000
1Peptide Hydrolases (Proteases)FDA Link
01/2000
1Capsules (Microcapsules)IBA
01/2000
1VaccinesIBA
01/2000
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2000
1MannansIBA
01/2000

Therapy/Procedure

8Therapeutics
01/2013 - 01/2000
5Radioimmunotherapy
01/2018 - 03/2004
2Immunotherapy
01/2018 - 09/2006
2Drug Therapy (Chemotherapy)
03/2013 - 10/2001
1Transplantation
12/2007
1Catheters
06/2006
1Highly Active Antiretroviral Therapy (HAART)
12/2000